Jeffrey Wang, Alexis K Okoh, Yuxuan Chen, Rebecca S Steinberg, Apoorva Gangavelli, Krishan J Patel, Yi-An Ko, Jeffrey D Alexis, Shivani A Patel, David J Vega, Mani Daneshmand, Ersilia M DeFilippis, Khadijah Breathett, Alanna A Morris
BACKGROUND: Among patients with advanced heart failure (HF), treatment with a left ventricular assist device (LVAD) improves health-related quality of life (HRQOL). We investigated the association between psychosocial risk factors, HRQOL, and outcomes after LVAD implantation. METHODS: A retrospective cohort (n=9832) of adults aged ≥ 19 years who received durable LVAD between 2008 - 2017 was identified using the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS)...
April 13, 2024: Journal of Cardiac Failure